Found 6 matching trials
Darusentan Effect on PET Uptake Heterogeneity PHASE2 The primary objective of this study is to test the hypothesis that myocardi...
Show More Location
Weatherhead PET Center for Preventing and Reversing Atherosclerosis, UT Medical School, Memorial Hermann Hospital
Learn More & Join Trial
A Clinical Study to Evaluate the Effects of Darusentan on Safety and Efficacy in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Blood Pressure Lowering Drugs PHASE2 This is a research study of a new experimental drug called darusentan. Daru...
Show More Location
Multiple Locations
Learn More & Join Trial
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension PHASE3 This is a randomized, double-blind, placebo- and active-controlled study of...
Show More Location
Alabama Internal Medicine, PC
Learn More & Join Trial
DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension PHASE3 This is a research study of a new experimental drug called darusentan. Daru...
Show More Location
UAB Hypertension Program
Learn More & Join Trial
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension PHASE3 This is a double-blind, active-controlled, long-term study of a new experim...
Show More Location
Alabama Internal Medicine, PC
Learn More & Join Trial
DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension PHASE3 This is a research study of a new experimental drug called darusentan. Daru...
Show More Location
Comprehensive Heart Failure Center
Learn More & Join Trial